Relay Therapeutics (RLAY) Metrics: History & Chart

Relay Therapeutics, Inc.(RLAY)

Biotechnology · Cambridge, MA

$18.41-0.98 (-5.04%)

Delayed quote: Oct 6, 2026, 3:40 PM EDT

About Relay Therapeutics, Inc.

Relay Therapeutics, Inc. is a precision medicine company currently engaged in clinical trials. Its central mission involves revolutionizing the drug discovery process, with a particular focus on enhancing the creation of small molecule therapies for specific types of cancer and genetic conditions. The company's pipeline features several promising drug candidates: RLY-4008, an orally administered small molecule designed to inhibit fibroblast growth factor receptor 2 (FGFR2), which is undergoing its initial human trials for patients with advanced or metastatic solid tumors exhibiting FGFR2 alterations; RLY-2608, a leading program targeting mutant phosphoinositide 3 kinase alpha (PI3Ka); and RLY-1971, another oral small molecule, an inhibitor of SHP2 (protein tyrosine phosphatase Src homology region 2 domain-containing phosphatase-2), currently in Phase 1 trials for individuals with advanced solid tumors. Relay Therapeutics has established strategic partnerships, including a collaboration with D. E. Shaw Research, LLC, which utilizes computational modeling to analyze protein motion for the identification and development of therapeutic compounds. Furthermore, an agreement with Genentech, Inc. supports the development and commercialization of RLY-1971. Founded in 2015 as Allostery, Inc., the company rebranded to Relay Therapeutics, Inc. in December of that year and maintains its headquarters in Cambridge, Massachusetts.

Cambridge, MA

202 employees

www.relaytx.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Sanjiv K. Patel

View full financials

Third-Party DCF Estimate (FMP)	N/A
Price Gap vs Third-Party Estimate	N/A

7D Total Return	+9.61%
30D Total Return	+1.84%
YTD Total Return	+129.20%
1Y Total Return	+253.83%
3Y Total Return	+117.11%
5Y Total Return	-33.80%
10Y Total Return	N/A
15Y Total Return	N/A
20Y Total Return	N/A

2026	+129.20%
2025	+105.34%
2024	-62.58%
2023	-26.31%
2022	-51.35%
2021	-26.11%
2020

CAGR TTM	+251.71%
CAGR 3Y	+29.48%
CAGR 5Y	-7.92%
CAGR 10Y	N/A
CAGR 15Y	N/A
CAGR 20Y	N/A

PE Ratio	N/A
PE Ratio Avg TTM	N/A
PE Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

All Metrics

RLAY Valuation Metrics

RLAY Stock Price Metrics

RLAY Dividend Metrics

RLAY Growth Rate Metrics

RLAY Discounted Cash Flow Metrics

RLAY Returns By Period

RLAY Yearly Returns

RLAY Average Annual Returns By Period (CAGR)

RLAY Revenue Metrics

RLAY PE Ratio Metrics

RLAY PS Ratio Metrics

RLAY PB Ratio Metrics

RLAY Price to Free Cash Flow Ratio Metrics

RLAY Debt to Equity Ratio Metrics

RLAY PEG Ratio Metrics

RLAY FCF Yield

RLAY Earnings Yield

RLAY EBITDA Yield

RLAY OCF Yield

RLAY EV/EBIT Ratio Metrics

RLAY EV/EBITDA Ratio Metrics

RLAY EV/Assets Ratio Metrics

RLAY EV/Sales Ratio Metrics

RLAY Current Ratio Metrics

RLAY Quick Ratio Metrics

RLAY ROIC Metrics

RLAY Return on Assets Metrics

RLAY Return on Equity Metrics

RLAY Net Profit Margin Metrics

RLAY Gross Profit Margin Metrics

RLAY Tax Rate Metrics

PS Ratio	380.02
PS Ratio Avg TTM	219.64
PS Ratio Avg 3Y	91.88
Current VS TTM Avg	+73.02%
Current VS 3Y Avg	+313.62%
Current VS 5Y Avg	-14.31%

PB Ratio	4.42
PB Ratio Avg TTM	3.42
PB Ratio Avg 3Y	1.57
Current VS TTM Avg	+29.29%
Current VS 3Y Avg	+181.67%
Current VS 5Y Avg	+103.51%

PFCF Ratio	N/A
PFCF Ratio Avg TTM	N/A
PFCF Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Debt/Equity Ratio	0.03
Debt/Equity Ratio Avg TTM	0.05
Debt/Equity Ratio Avg 3Y	0.06
Current VS TTM Avg	-30.28%
Current VS 3Y Avg	-43.26%
Current VS 5Y Avg	-36.22%

PEG Ratio	N/A
PEG Ratio Avg TTM	N/A
PEG Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

FCF Yield	N/A
FCF Yield Avg TTM	N/A
FCF Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Earnings Yield	N/A
Earnings Yield Avg TTM	N/A
Earnings Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

EBITDA Yield	N/A
EBITDA Yield Avg TTM	N/A
EBITDA Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

OCF Yield	N/A
OCF Yield Avg TTM	N/A
OCF Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Ebit Ratio	N/A
Ev/Ebit Ratio Avg TTM	N/A
Ev/Ebit Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Ebitda Ratio	N/A
Ev/Ebitda Ratio Avg TTM	N/A
Ev/Ebitda Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Assets Ratio	3.97
Ev/Assets Ratio Avg TTM	3.00
Ev/Assets Ratio Avg 3Y	1.29
Current VS TTM Avg	+32.43%
Current VS 3Y Avg	+207.72%
Current VS 5Y Avg	+120.40%

Ev/Sales Ratio	371.28
Ev/Sales Ratio Avg TTM	210.46
Ev/Sales Ratio Avg 3Y	85.18
Current VS TTM Avg	+76.42%
Current VS 3Y Avg	+335.86%
Current VS 5Y Avg	-9.36%

Current Ratio	18.27
Current Ratio Avg TTM	20.61
Current Ratio Avg 3Y	19.07
Current VS TTM Avg	-11.38%
Current VS 3Y Avg	-4.22%
Current VS 5Y Avg	-4.73%

Quick Ratio	18.27
Quick Ratio Avg TTM	20.61
Quick Ratio Avg 3Y	19.07
Current VS TTM Avg	-11.38%
Current VS 3Y Avg	-4.22%
Current VS 5Y Avg	-4.64%

ROIC	(33.87%)
ROIC Avg 3Y	(46.21%)
ROIC Avg 5Y	(41.21%)
Current VS 3Y Avg	+26.71%
Current VS 5Y Avg	+17.83%
Current VS 10Y Avg	+6.37%

ROA	(29.57%)
ROA Avg TTM	(9.74%)
ROA Avg 3Y	(9.65%)
Current VS TTM Avg	-203.69%
Current VS 3Y Avg	-206.28%
Current VS 5Y Avg	-220.65%

ROE	(32.14%)
ROE Avg TTM	(43.83%)
ROE Avg 3Y	(44.93%)
Current VS TTM Avg	+26.67%
Current VS 3Y Avg	+28.47%
Current VS 5Y Avg	+22.58%

Net Profit Margin	(2763.64%)
Net Profit Margin Avg TTM	(7507.72%)
Net Profit Margin Avg 3Y	(589.43%)
Current VS TTM Avg	+63.19%
Current VS 3Y Avg	-368.87%
Current VS 5Y Avg	+75.26%

Gross Profit Margin	76.83%
Gross Pft Margin Avg TTM	(1741.08%)
Gross Pft Margin Avg 3Y	16.81%
Current VS TTM Avg	+104.41%
Current VS 3Y Avg	+357.08%
Current VS 5Y Avg	+101.34%

Tax Rate	0.00%
Tax Rate Avg 3Y	N/A
Tax Rate Avg 5Y	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A
Current VS 10Y Avg	N/A